Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1947 2
1948 2
1949 7
1950 3
1951 3
1952 2
1953 4
1954 1
1955 1
1956 2
1958 1
1959 2
1960 4
1961 8
1962 9
1963 7
1964 3
1965 2
1967 2
1968 1
1969 2
1970 1
1971 3
1972 2
1973 1
1979 1
1983 2
1984 1
1985 2
1986 2
1987 2
1988 2
1989 3
1990 3
1991 7
1992 7
1993 3
1994 5
1995 8
1996 6
1998 1
2000 3
2002 1
2006 2
2007 1
2008 2
2009 3
2010 5
2011 2
2012 3
2013 2
2014 4
2015 8
2016 6
2017 2
2018 7
2019 10
2020 7
2021 4
2022 7
2023 11
2024 10
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

218 results

Results by year

Filters applied: . Clear all
Page 1
γ-Secretase inhibitor in combination with BCMA chimeric antigen receptor T-cell immunotherapy for individuals with relapsed or refractory multiple myeloma: a phase 1, first-in-human trial.
Cowan AJ, Pont MJ, Sather BD, Turtle CJ, Till BG, Libby EN 3rd, Coffey DG, Tuazon SA, Wood B, Gooley T, Wu VQ, Voutsinas J, Song X, Shadman M, Gauthier J, Chapuis AG, Milano F, Maloney DG, Riddell SR, Green DJ. Cowan AJ, et al. Among authors: pont mj. Lancet Oncol. 2023 Jul;24(7):811-822. doi: 10.1016/S1470-2045(23)00246-2. Lancet Oncol. 2023. PMID: 37414012 Free PMC article. Clinical Trial.
Acquired CD38 gene deletion as a mechanism of tumor antigen escape in multiple myeloma.
Portuguese AJ, Fang M, Tuazon SA, Pont M, Qu X, Shasha C, Comstock M, Lyons J, Cole G, Newell EW, Glynn E, Soma LA, Green DJ. Portuguese AJ, et al. Among authors: pont m. Blood Adv. 2023 Dec 12;7(23):7235-7238. doi: 10.1182/bloodadvances.2023011295. Blood Adv. 2023. PMID: 37844282 Free PMC article. No abstract available.
Influence of vascular imaging acquisition at local stroke centers on workflows in the drip-n-ship model: a RACECAT post hoc analysis.
Flores A, Garcia-Tornel A, Seró L, Ustrell X, Requena M, Pellisé A, Rodriguez P, Monterde A, Lara L, Gonzalez-de-Echavarri JM, Molina CA, Doncel-Moriano A, Dorado L, Cardona P, Cánovas D, Krupinski J, Más N, Purroy F, Zaragoza-Brunet J, Palomeras E, Cocho D, Garcia J, Colom C, Silva Y, Gomez-Cocho M, Jiménez X, Ros-Roig J, Abilleira S, Pérez de la Ossa N, Ribo M; RACECAT trial investigators. Flores A, et al. J Neurointerv Surg. 2024 Jan 12;16(2):143-150. doi: 10.1136/jnis-2023-020125. J Neurointerv Surg. 2024. PMID: 37068936 Clinical Trial.
Imaging of post-mortem human brain tissue using electron and X-ray microscopy.
Lewis AJ, Genoud C, Pont M, van de Berg WD, Frank S, Stahlberg H, Shahmoradian SH, Al-Amoudi A. Lewis AJ, et al. Among authors: pont m. Curr Opin Struct Biol. 2019 Oct;58:138-148. doi: 10.1016/j.sbi.2019.06.003. Epub 2019 Jul 23. Curr Opin Struct Biol. 2019. PMID: 31349127 Free article. Review.
Identification of novel small molecule-based strategies of COL7A1 upregulation and readthrough activity for the treatment of recessive dystrophic epidermolysis bullosa.
Jover I, Ramos MC, Escámez MJ, Lozoya E, Tormo JR, de Prado-Verdún D, Mencía Á, Pont M, Puig C, Larraufie MH, Gutiérrez-Caballero C, Reyes F, Trincado JL, García-González V, Cerrato R, Andrés M, Crespo M, Vicente F, Godessart N, Genilloud O, Larcher F, Nueda A. Jover I, et al. Among authors: pont m. Sci Rep. 2024 Aug 16;14(1):18969. doi: 10.1038/s41598-024-67398-8. Sci Rep. 2024. PMID: 39152155 Free PMC article.
218 results